IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session Why Linkage LGCB deserves a spot in every portfolio Tick Down 20260503 NPCT Nuveen quarterly earnings details remain undisclosed investors await updates on its impact fund portfolio performance MUZEU Muzero outlines new crosssector strategic acquisition priorities during its latest quarterly earnings call AXP Q1 2026 Earnings EPS Beat Drives Cautious Optimism FTAI Q1 2026 Earnings EPS Misses Estimates as Stock Gains 23 ASC Q1 2026 Earnings Strong EPS Beat Amidst Operational Gains HDB Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher PGY Q1 2026 Earnings EPS Surges 263 Above Estimates Amid Strong Performance PNTG Q1 2026 Earnings Modest EPS Beat Fails to Lift Stock